Figure 3
From: Liraglutide reduces body weight by upregulation of adenylate cyclase 3
BWs, FBG levels, HOMA-IR scores and serum AC3 levels in mice treated with liraglutide (L) or saline (S). The BWs, FBG levels, HOMA-IR scores and serum AC3 levels observed after treatment with liraglutide or saline are summarized in (a–d), respectively. The P-values for the effect of the interaction between obesity and liraglutide treatment on BWs, FBG levels, HOMA-IR scores and serum AC3 levels are 0.350, 0.065, 0.008 and 0.736, respectively. Values are presented as means±s.d. (n=6 per group). *P<0.05, **P<0.01 for the comparison of the saline and liraglutide groups; #P<0.05, ##P<0.01 for the comparison of the normal and obese groups.
